Genetically modified bacillus subtilis strain and use as a live delivery and production system
US-2024390433-A1 · Nov 28, 2024 · US
US2018298389A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2018298389-A1 |
| Application number | US-201715574028-A |
| Country | US |
| Kind code | A1 |
| Filing date | Apr 24, 2017 |
| Priority date | Apr 25, 2016 |
| Publication date | Oct 18, 2018 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed are a recombinant Corynebacterium glutamicum (C. glutamicum) for producing fucosyllactose which is transformed to express α-1,2-fucosyltransferase, GDP-D-mannose-4,6-dehydratase (Gmd), GDP-L-fucose synthase (WcaG) and lactose permease (LacY), wherein the Corynebacterium glutamicum has phosphomannomutase and GTP-mannose-1-phosphate guanylyltransferase, and a method for producing fucosyllactose using the same. According to the recombinant Corynebacterium glutamicum and the method for producing fucosyllactose according to the present invention, with use of a GRAS Corynebacterium glutamicum strain, which is safer than conventional Escherichia coli, 2′-fucosyllactose can be produced at a high concentration while overcoming drawbacks of conventional methods associated with industrial inapplicability resulting from low production concentrations.
Opening claim text (preview).
1 . A recombinant Corynebacterium glutamicum transformed to express α-1,2-fucosyltransferase, transformed to express GDP-D-mannose-4,6-dehydratase, transformed to express GDP-L-fucose synthase, and transformed to express lactose permease, wherein the recombinant Corynebacterium glutamicum has phosphomannomutase and GTP-mannose-1-phosphate guanylyltransferase. 2 . The recombinant Corynebacterium glutamicum according to claim 1 , wherein the α-1,2-fucosyltransferase is encoded by fucT2 genes. 3 . The recombinant Corynebacterium glutamicum according to claim 2 , wherein the fucT2 genes have the nucleic acid sequence of SEQ ID NO: 6. 4 . The recombinant Corynebacterium glutamicum according to claim 1 , wherein the recombinant Corynebacterium glutamicum is transformed to overexpress phosphomannomutase, and transformed to overexpress GTP-mannose-1-phosphate guanylyltransferase. 5 . A method of producing 2′-fucosyllactose comprising culturing the recombinant Corynebacterium glutamicum according to claim 1 in a medium supplemented with lactose. 6 . The method according to claim 5 , wherein the medium further comprises glucose. 7 . The method according to claim 6 , wherein the production of the fucosyllactose is carried out by fed-batch culture comprising further supplying glucose or lactose.
GDP-4-dehydro-D-rhamnose reductase (1.1.1.187) · CPC title
Galactoside 2-alpha-L-fucosyltransferase (2.4.1.69) · CPC title
3-Galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase (2.4.1.65), i.e. alpha-1-3 fucosyltransferase · CPC title
Genes encoding for enzymes or proenzymes · CPC title
GDP-mannose 4,6-dehydratase (4.2.1.47), i.e. GMD · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.